Debate: Prostate Cancer Patients Should/Should Not Get Chemo and ADT as a Standard of Care
Dr. Karim Fizazi and Dr. Bertrand Tombal presented a debate on “Hormone-Naive Metastatic Prostate...
Read MoreSelect Page
Posted by Bertrand Tombal, MD, PhD | Feb 2017
Dr. Karim Fizazi and Dr. Bertrand Tombal presented a debate on “Hormone-Naive Metastatic Prostate...
Read MorePosted by Mark Emberton, MD, FRCS | Feb 2017
Dr. Mark Emberton presented “Focal Therapy for Men with Intermediate Risk Prostate Cancer and a...
Read MorePosted by Axel Merseburger, MD, PhD | Feb 2017
Dr. Axel Merseburger presented “Predicting Survival of Men with Prostate Cancer after RP” at the...
Read MorePosted by Alexander Lyon, MD, PhD | Feb 2017
Dr. Alexander Lyon presented “Prevalence of CVD and Assessment of CV Risk in Patients with...
Read MorePosted by Laurence Klotz, MD, FRCSC | Feb 2017
Laurence Klotz, MD presented “Active Surveillance or: Shrinking the Gray Zone” at the 6th...
Read More